Kodiak Sciences Inc. announced the appointment of Charles Bancroft to its board of directors. Charlie recently retired from a successful career at Bristol Myers Squibb (BMS) where he held a number of leadership roles in commercial, strategy and finance. Beginning his career at BMS in 1984, he held numerous roles of increasing responsibility. He served as Chief Financial Officer from 2010 to 2019 and was appointed Executive Vice President, Head of Integration and Strategy & Business Development in 2019. Charlie served as a member of the board of Colgate-Palmolive Company from 2017 to March 2020. He was appointed to GlaxoSmithKline's board of directors as a Non-Executive Director in March 2020.